Mkts

TriSalus Life Sciences, Inc.

NASDAQ: TLSI
$2.32+0.14 (+6.67%)
As of Nov 20, 4:00 PM ET

Key statistics

Day range
2.192.37
52-week range
2.177.95
Today
Open2.19
Previous close2.32
Volume—
Valuation
Market cap134.20M
P/E ratio—
EPS (TTM)-0.49
Income & risk
Dividend / yield—
Beta0.68
Avg volume278.1K
Discussion

TLSI News

Stories mentioning TLSI from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue8,89913,20511,56611,2139,1678,2617,3497,364
Cost of Goods Sold1,2301,7621,9061,8021,4951,2161,004912.00
Gross Profit7,66911,4439,6609,4117,6727,0456,3456,452
Operating Expenses
Research & Development3,2162,8455,1763,9233,0212,9594,2194,666
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(8,411)(3,271)(9,014)(7,332)(7,329)(7,580)(8,739)(8,174)
Interest Income164.00177.00170.00134.0074.0057.00158.0097.00
Interest Expense877.00
Other Expense(76.00)(71.00)(94.00)(40.00)(251.00)(102.00)(13.00)(44.00)
Pretax Income1,543(9,753)(10,806)(8,291)(10,370)(10,109)(2,402)(4,325)
Tax Provision4.000.005.00(3.00)5.00(1.00)(3.00)7.00
Net Income (Loss)1,539(9,753)(10,811)(8,288)(10,375)(10,108)(2,399)(4,332)
Earnings Per Share (Basic)0.03(0.26)(0.96)(0.27)(0.39)(0.40)(0.12)(0.21)
Earnings Per Share (Diluted)0.03(0.26)(0.96)(0.27)(0.39)(0.40)(0.12)(0.21)
Weighted Average Shares Outstanding (Basic)51,54037,89843,05832,89928,52725,33226,50223,904
Weighted Average Shares Outstanding (Diluted)52,31437,89843,05832,89928,52725,33226,50223,904

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About TLSI

TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is a stock listed on the Nasdaq Stock Market under the ticker symbol TLSI. It last traded at $2.32 (Nov 20, 2026, 4:00 PM ET), up 6.7% on the day. That gives TriSalus Life Sciences a market capitalisation of $134.2M.

Over the past 52 weeks TLSI has traded between $2.17 and $7.95.

Revenue for the quarter ended Mar 31, 2026 was $8.9M; net income $1.5M. Revenue was down 2.9% from $9.2M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$8.9M$1.5M17.3%
Dec 31, 2025$13.2M-$9.8M-73.9%
Sep 30, 2025$11.6M-$10.8M-93.5%
Jun 30, 2025$11.2M-$8.3M-73.9%

From TriSalus Life Sciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…